🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the makers of acetaminophen, asserting the corporations concealed alleged dangers that the medication presented to pediatric cognitive development.

This legal action comes a month after President Donald Trump publicized an unverified association between taking Tylenol - referred to as acetaminophen - throughout gestation and autism in offspring.

Paxton is taking legal action against Johnson & Johnson, which once produced the drug, the exclusive pain medication suggested for expectant mothers, and the current manufacturer, which presently makes it.

In a official comment, he said they "misled consumers by gaining financially from suffering and promoting medication without regard for the risks."

The company says there is no credible evidence tying Tylenol to autism.

"These manufacturers misled for generations, intentionally threatening countless individuals to increase profits," Paxton, from the Republican party, said.

The manufacturer commented that it was "deeply concerned by the dissemination of inaccurate information on the safety of paracetamol and the likely effects that could have on the welfare of women and children in America."

On its official site, the company also mentioned it had "continuously evaluated the relevant science and there is no credible data that shows a verified association between taking paracetamol and autism spectrum disorder."

Groups speaking for doctors and health professionals agree.

The American College of Obstetricians and Gynecologists has stated acetaminophen - the key substance in acetaminophen - is among limited choices for expectant mothers to treat pain and elevated temperature, which can create significant medical dangers if ignored.

"In more than two decades of investigation on the consumption of paracetamol in pregnancy, not a single reputable study has definitively established that the consumption of paracetamol in any period of pregnancy causes brain development issues in children," the association said.

This legal action mentions recent announcements from the Trump administration in arguing the drug is potentially dangerous.

In recent weeks, the former president generated worry from health experts when he advised women during pregnancy to "resist strongly" not to use acetaminophen when sick.

Federal regulators then issued a notice that medical professionals should consider limiting the usage of Tylenol, while also stating that "a causal relationship" between the drug and autism in minors has not been established.

The Health Department head RFK Jr, who manages the FDA, had pledged in April to conduct "comprehensive study program" that would identify the origin of autism spectrum disorder in a limited time.

But authorities advised that finding a single cause of autism - thought by researchers to be the outcome of a intricate combination of genetic and external influences - would not be simple.

Autism spectrum disorder is a category of lifelong neurodivergence and disability that impacts how persons experience and interact with the environment, and is recognized using physician assessments.

In his lawsuit, the attorney general - who supports Trump who is campaigning for the Senate - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

This legal action aims to force the companies "eliminate any commercial messaging" that asserts acetaminophen is reliable for expectant mothers.

This legal action parallels the concerns of a assembly of guardians of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in 2022.

The court rejected the lawsuit, saying investigations from the parents' expert witnesses was not conclusive.